Healthcare
Bmp exits Pomocni
bmp has sold its 17.24% stake in online childcare platform Pomocni to Edipresse Polska.
Sud Investments leads financing in PneumaCare
Sud Investments has led a £2m round of funding for PneumaCare Ltd, together with a group of existing investors including Cambridge Enterprise, Cambridge Capital Group, Plextek Ltd and members of the Cambridge Angels group.
Consortium sells Carmel Pharma stake
A consortium, consisting of Priveq Investment, Investor Growth Capital, Industrifonden, Start Invest and employees, has sold 95% of the shareholding in Swedish pharmaceutical company Carmel Pharma AB.
Imperial Innovations backs Stanmore Implants
Imperial Innovations Group has invested €4m in customised implants specialist Stanmore Implants.
Consortium invest £16.9m in Atlas Genetics
A consortium, led by Novartis Venture and Consort Medical, has invested £16.9m in diagnostic company Atlas Genetics Ltd.
EQT acquires Atos from Nordic Capital
EQT has acquired Swedish medical device company Atos Medical from Nordic Capital.
S-Refit et al. close finance round for Lophius
Venture capital firms S-Refit, High-Tech Gründerfonds and Bayernkapital have closed a €1.4m financing round for diagnostic test systems developer Lophius Biosciences.
Mid Europa signs first Turkish deal
Mid Europa has done its first deal in Turkey with the backing of Kent Hospital Group.
VCs exit BiancaMed in trade sale
VC-backed Irish medical equipment company BiancaMed has been acquired by ResMed, in a deal that values the company at less than $50m.
MIG AG backs Antisense Pharma in new €8m round
Retail fund manager MIG Verwaltungs AG and Global Asset Management have invested a further €8m in biotechnology company Antisense Pharma GmbH.
Is pharma losing out on venture funding?
Despite mass publicity, early-stage software and technology companies have often played second fiddle to pharma on funding, but this could be about to change. John Bakie investigates
Incitia partially exits Algeta – reaps 8x
Incitia Ventures has sold 50% of its shareholding in Oslo-based biotech company Algeta ASA, generating an 8x return on investment.
Consortium provides €7m funding for NonWoTecc
NRW.Bank, Rheinland Venture Capital, Kreissparkasse Köln, HTGF and KfW have backed NonWoTecc Medical in a second financing round worth €7m.
Creathor Venture and HTGF invest in Sirion Biotech
Creathor Venture and current investors HTGF, KfW and Bayerkapital have invested in biotechnology company Sirion Biotech.
LSP et al. invest €8.1m in Mendor
A consortium, consisting of Life Sciences Partners (LSP), Finnish entrepreneur Risto Siilasmaa, Finnish Industry Investment, Ilmarinen Mutual Pension Insurance Company, Biothom and Finnvera Venture Capital, has participated in a €8.1m series-B funding...
Altor acquires Orchid Orthopedic
Altor has acquired US-based orthopaedic and dental implant company Orchid Orthopedic Solutions from Churchill Equity.
VCs reap 3x return on Dexela sale
Albion Ventures and the London Technology Fund (LTF) have sold UK-based medical equipment company Dexela to US healthcare firm PerkinElmer Inc. for an undisclosed amount.
Spark Impact appoints two
Early-stage VC firm Spark Impact has appointed Marc d'Abbadie and Andy Round as investment director and investment manager respectively.
PE-backed Vivalto Santé acquires new clinic in France
Vivalto Santé, a French private healthcare company partly owned by a consortium of private equity investors, has acquired Polyclinique de la Baie d'Avranches for an undisclosed amount.
CAN backs Laboratorios Ojer Pharma with €500,000
Corporación Caja Navarra (CAN), the private equity arm of Caja Navarra, has invested €500,000 in biotech company Laboratorios Ojer Pharma in return for a 11.22% in the business.
HTGF et al. make follow on investment in m2p-labs
High-Tech-Gründerfonds, KfW, the Seed Fund for the Region of Aachen and the ERP Start-UP Fund have backed biotechnology company m2p-labs with a third round of funding.
Azulis Capital buys Lagarrigue from iXO
Azulis Capital has taken a majority stake in the secondary buyout of French medical equipment business Lagarrigue from iXO Private Equity.
BC Partners further exits Médica
TBU-3 International, a holding owned by BC Partners, has sold a 28.1% stake in listed French homecare company Médica.
PE-backed AES Laboratoire sold for €183m
Abénex Capital, EPF Partners, Fortis PE and BNP Paribas have exited French microbiology company AES Laboratoire in a €183m trade sale to bioMérieux.